Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Raeven, René H M ^a,b   Brummelman, Jolanda ^c   Pennings, Jeroen L A ^c   Nijst, Olaf E M ^a   Kuipers, Betsy ^c   Blok, Laura E R ^a   Helm, Kina ^c   Van Riet, Elly ^a   Jiskoot, Wim ^b   Van Els, Cecile A C M ^c   Han, Wanda G H ^c   Kersten, Gideon F A ^a,b   Metz, Bernard ^a  

^a Intravacc ^*  (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEMBRANE RECEPTOR; PERTUSSIS VACCINE; TRANSCRIPTION FACTOR; ALPHA DEFENSIN; BACTERIUM ANTIBODY; CELL SURFACE RECEPTOR; CYTOKINE;

ACUTE PHASE RESPONSE; ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL CLEARANCE; BLOOD; BORDETELLA PERTUSSIS; CD4+ T LYMPHOCYTE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNITY; IMMUNOASSAY; INNATE IMMUNITY; LUNG; MEMORY CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERTUSSIS; PHAGOCYTOSIS; RECOGNITION; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH17 CELL; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BORDETELLOSIS; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY;

ADAPTIVE IMMUNITY; ALPHA-DEFENSINS; ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA INFECTIONS; BORDETELLA PERTUSSIS; COMPLEMENT ACTIVATION; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; IMMUNOGLOBULIN A; IMMUNOLOGIC MEMORY; LUNG; MICE; MICE, INBRED BALB C; RECEPTORS, CELL SURFACE; SPLEEN; TH1 CELLS; TH17 CELLS; TRANSCRIPTION FACTORS;

EID: 84940217051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104548     Document Type: Article

References (117)

1. Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18: 326-382. (Pubitemid 40548297)
2. Cherry JD (2012) Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med 367: 785-787.
3. Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein NP (2013) Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 347: f4249.
4. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE (2005) Resurgence of pertussis in Europe. Pediatr Infect Dis J 24: 761-765. (Pubitemid 41324882)
5. Kretzschmar M, Teunis PF, Pebody RG (2010) Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 7: e1000291.
6. Mooi FR, NA VDM, De Melker HE (2013) Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect: 1-10.
7. Mann PB, Kennett MJ, Harvill ET (2004) Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis 189: 833-836. (Pubitemid 38328184)
8. Banus HA, Vandebriel RJ, de Ruiter H, Dormans JA, Nagelkerke NJ, et al. (2006) Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect Immun 74: 2596-2605. (Pubitemid 43672967)
9. Banus S, Pennings J, Vandebriel R, Wester P, Breit T, et al. (2007) Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling. Immunogenetics 59: 555-564. (Pubitemid 46850165)
10. Moreno G, Errea A, Van Maele L, Roberts R, Leger H, et al. (2013) Toll-like receptor 4 orchestrates neutrophil recruitment into airways during the first hours of Bordetella pertussis infection. Microbes Infect.
11. Mills KH, Barnard A, Watkins J, Redhead K (1993) Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 61: 399-410. (Pubitemid 23030823)
12. Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, et al. (2013) Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 9: e1003264.
13. Warfel JM, Merkel TJ (2013) Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 6: 787-796.
14. Wendelboe AM, Van Rie A, Salmaso S, Englund JA (2005) Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 24: S58-61. (Pubitemid 40676539)
15. Warfel JM, Zimmerman LI, Merkel TJ (2014) Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 111: 787-792.
16. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A (1997) Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 65: 2168-2174. (Pubitemid 27237293)
17. Mills KH, Ryan M, Ryan E, Mahon BP (1998) A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun 66: 594-602. (Pubitemid 28074200)
18. Canthaboo C, Williams L, Xing DK, Corbel MJ (2000) Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines. Vaccine 19: 637-643.
19. Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR, van de Winkel JG (2001) Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect Immun 69: 4846-4850. (Pubitemid 32674464)
20. Leef M, Elkins KL, Barbic J, Shahin RD (2000) Protective immunity to Bordetella pertussis requires both B cells and CD4 (+) T cells for key functions other than specific antibody production. J Exp Med 191: 1841-1852. (Pubitemid 30390348)
21. Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, et al. (1997) Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis 175: 1246-1250. (Pubitemid 27176522)
22. Kirimanjeswara GS, Mann PB, Harvill ET (2003) Role of antibodies in immunity to Bordetella infections. Infect Immun 71: 1719-1724. (Pubitemid 36368699)
23. Hendrikx LH, Ozturk K, de Rond LG, de Greeff SC, Sanders EA, et al. (2011) Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics. PLoS One 6: e27681.
24. Brandes M, Klauschen F, Kuchen S, Germain RN (2013) A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154: 197-212.
25. Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, et al. (2013) Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation. Cell 154: 213-227.
26. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
27. Vandebriel RJ, Hellwig SM, Vermeulen JP, Hoekman JH, Dormans JA, et al. (2003) Association of Bordetella pertussis with host immune cells in the mouse lung. Microb Pathog 35: 19-29. (Pubitemid 36809186)
28. van Kooyk Y (2008) C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans 36: 1478-1481.
29. Kikutani H, Kumanogoh A (2003) Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol 3: 159-167. (Pubitemid 37328693)
30. Gianchecchi E, Delfino DV, Fierabracci A (2013) Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity. Autoimmun Rev.
31. Doi T, Kanai T, Mikami Y, Sujino T, Jun L, et al. (2012) IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestine. Biochem Biophys Res Commun 425: 918-923.
32. Alcaide P, Maganto-Garcia E, Newton G, Travers R, Croce KJ, et al. (2012) Difference in Th1 and Th17 lymphocyte adhesion to endothelium. J Immunol 188: 1421-1430.
33. Ito T, Carson WFt, Cavassani KA, Connett JM, Kunkel SL (2011) CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res 317: 613-619.
34. Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T (2003) Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 28: 648-654. (Pubitemid 36681535)
35. Kohrgruber N, Groger M, Meraner P, Kriehuber E, Petzelbauer P, et al. (2004) Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J Immunol 173: 6592-6602. (Pubitemid 39541042)
36. Evans SE, Xu Y, Tuvim MJ, Dickey BF (2010) Inducible innate resistance of lung epithelium to infection. Annu Rev Physiol 72: 413-435.
37. Schroll A, Eller K, Feistritzer C, Nairz M, Sonnweber T, et al. (2012) Lipocalin-2 ameliorates granulocyte functionality. Eur J Immunol 42: 3346-3357.
38. Nishimura J, Saiga H, Sato S, Okuyama M, Kayama H, et al. (2008) Potent antimycobacterial activity of mouse secretory leukocyte protease inhibitor. J Immunol 180: 4032-4039.
39. Saiga H, Nishimura J, Kuwata H, Okuyama M, Matsumoto S, et al. (2008) Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol 181: 8521-8527.
40. Dela Cruz CS, Liu W, He CH, Jacoby A, Gornitzky A, et al. (2012) Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe 12: 34-46.
41. Pisabarro MT, Leung B, Kwong M, Corpuz R, Frantz GD, et al. (2006) Cutting edge: novel human dendritic cell- and monocyte-attracting chemokinelike protein identified by fold recognition methods. J Immunol 176: 2069-2073. (Pubitemid 43201652)
42. Burkhardt AM, Tai KP, Flores-Guiterrez JP, Vilches-Cisneros N, Kamdar K, et al. (2012) CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol 188: 6399-6406.
43. Miyake K, Ogata H, Nagai Y, Akashi S, Kimoto M (2000) Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1. J Endotoxin Res 6: 389-391. (Pubitemid 32241949)
44. Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, et al. (2008) Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 319: 624-627. (Pubitemid 351197065)
45. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, et al. (2007) DAI (DLM- 1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505. (Pubitemid 47123520)
46. Powlesland AS, Ward EM, Sadhu SK, Guo Y, Taylor ME, et al. (2006) Widely divergent biochemical properties of the complete set of mouse DC-SIGNrelated proteins. J Biol Chem 281: 20440-20449. (Pubitemid 44065817)
47. Vukman KV, Ravida A, Aldridge AM, O'Neill SM (2013) Mannose receptor and macrophage galactose-type lectin are involved in Bordetella pertussis mast cell interaction. J Leukoc Biol.
48. Turkistany SA, DeKoter RP (2011) The transcription factor PU.1 is a critical regulator of cellular communication in the immune system. Arch Immunol Ther Exp (Warsz) 59: 431-440.
49. Carotta S, Wu L, Nutt SL (2010) Surprising new roles for PU.1 in the adaptive immune response. Immunol Rev 238: 63-75.
50. Male V, Nisoli I, Gascoyne DM, Brady HJ (2012) E4BP4: an unexpected player in the immune response. Trends Immunol 33: 98-102.
51. Perry AK, Chen G, Zheng D, Tang H, Cheng G (2005) The host type I interferon response to viral and bacterial infections. Cell Res 15: 407-422. (Pubitemid 41642869)
52. Miyagawa F, Zhang H, Terunuma A, Ozato K, Tagaya Y, et al. (2012) Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells. Proc Natl Acad Sci U S A 109: 12123-12128.
53. Shin DM, Lee CH, Morse HC, 3rd (2011) IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells. PLoS One 6: e27384.
54. Marquis JF, Kapoustina O, Langlais D, Ruddy R, Dufour CR, et al. (2011) Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet 7: e1002097.
55. Zurita E, Moreno G, Errea A, Ormazabal M, Rumbo M, et al. (2013) The Stimulated Innate Resistance Event in Bordetella pertussis Infection Is Dependent on Reactive Oxygen Species Production. Infect Immun 81: 2371-2378.
56. Gibbings D, Befus AD (2009) CD4 and CD8: an inside-out coreceptor model for innate immune cells. J Leukoc Biol 86: 251-259.
57. Stoeckle C, Gouttefangeas C, Hammer M, Weber E, Melms A, et al. (2009) Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs. Exp Hematol 37: 266-275.
58. Nitschke L (2005) The role of CD22 and other inhibitory co-receptors in B-cell activation. Curr Opin Immunol 17: 290-297.
59. Flak TA, Heiss LN, Engle JT, Goldman WE (2000) Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. Infect Immun 68: 1235-1242. (Pubitemid 30108516)
60. Clark-Lewis I, Mattioli I, Gong JH, Loetscher P (2003) Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J Biol Chem 278: 289-295. (Pubitemid 36043575)
61. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, et al. (1994) Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179: 881-887. (Pubitemid 24065646)
62. Sallusto F, Mackay CR, Lanzavecchia A (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007. (Pubitemid 27449145)
63. Schmitt E, Van Brandwijk R, Fischer HG, Rude E (1990) Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors. Eur J Immunol 20: 1709-1715. (Pubitemid 20290903)
64. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, et al. (2008) Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9: 1341-1346.
65. Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, et al. (2009) IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 206: 1653-1660.
66. Roberts AW (2005) G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors 23: 33-41.
67. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, et al. (2005) Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22: 285-294. (Pubitemid 40387471)
68. Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, et al. (2013) Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol 9: 659.
69. Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, et al. (2007) An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 179: 7791-7799.
70. Nishida M, Suda R, Nagamatsu Y, Tanabe S, Onohara N, et al. (2010) Pertussis toxin up-regulates angiotensin type 1 receptors through Toll-like receptor 4-mediated Rac activation. J Biol Chem 285: 15268-15277.
71. Jeyaseelan S, Manzer R, Young SK, Yamamoto M, Akira S, et al. (2005) Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. Am J Respir Cell Mol Biol 32: 531-539. (Pubitemid 40770131)
72. Bozic CR, Kolakowski LF, Jr., Gerard NP, Garcia-Rodriguez C, von Uexkull-Guldenband C, et al. (1995) Expression and biologic characterization of the murine chemokine KC. J Immunol 154: 6048-6057.
73. Boyd AP, Ross PJ, Conroy H, Mahon N, Lavelle EC, et al. (2005) Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J Immunol 175: 730-738. (Pubitemid 41094953)
74. Carbonetti NH (2007) Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr Opin Pharmacol 7: 272-278.
75. Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET (2005) Pertussis toxin inhibits neutrophil recruitment to delay antibodymediated clearance of Bordetella pertussis. J Clin Invest 115: 3594-3601. (Pubitemid 43121848)
76. Andreasen C, Carbonetti NH (2008) Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun 76: 5139-5148.
77. McGuirk P, McCann C, Mills KH (2002) Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 195: 221-231. (Pubitemid 34461266)
78. Hozbor D, Rodriguez ME, Fernandez J, Lagares A, Guiso N, et al. (1999) Release of outer membrane vesicles from Bordetella pertussis. Curr Microbiol 38: 273-278. (Pubitemid 29203163)
79. Kuehn MJ, Kesty NC (2005) Bacterial outer membrane vesicles and the hostpathogen interaction. Genes Dev 19: 2645-2655. (Pubitemid 41627932)
80. Ellis TN, Kuehn MJ (2010) Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74: 81-94.
81. McGuirk P, Mahon BP, Griffin F, Mills KH (1998) Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur J Immunol 28: 153-163. (Pubitemid 28048286)
82. Rodriguez ME, Hellwig SM, Hozbor DF, Leusen J, van der Pol WL, et al. (2001) Fc receptor-mediated immunity against Bordetella pertussis. J Immunol 167: 6545-6551. (Pubitemid 33081590)
83. den Dunnen J, Gringhuis SI, Geijtenbeek TB (2009) Innate signaling by the Ctype lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother 58: 1149-1157.
84. Dirix V, Verscheure V, Vermeulen F, De Schutter I, Goetghebuer T, et al. (2012) Both CD4(+) and CD8(+) lymphocytes participate in the IFN-gamma response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults. Clin Dev Immunol 2012: 795958.
85. Aoki N, Zganiacz A, Margetts P, Xing Z (2004) Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection. Infect Immun 72: 2477-2483. (Pubitemid 38542372)
86. Nakano-Yokomizo T, Tahara-Hanaoka S, Nakahashi-Oda C, Nabekura T, Tchao NK, et al. (2011) The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses. J Exp Med 208: 1661-1671.
87. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, et al. (2006) Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 177: 2051-2055. (Pubitemid 44200961)
88. Takagi H, Fukaya T, Eizumi K, Sato Y, Sato K, et al. (2011) Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 35: 958-971.
89. Borrego F (2013) The CD300 molecules: an emerging family of regulators of the immune system. Blood 121: 1951-1960.
90. Clark GJ, Ju X, Tate C, Hart DN (2009) The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol 30: 209-217.
91. Nimmerjahn F, Ravetch JV (2007) Fc-receptors as regulators of immunity. Adv Immunol 96: 179-204. (Pubitemid 350018720)
92. Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, et al. (2002) T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol 3: 549-557. (Pubitemid 34662307)
93. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17- producing T helper memory cells. Nat Immunol 8: 639-646. (Pubitemid 46785128)
94. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, et al. (1999) CCchemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 162: 186-194. (Pubitemid 29018919)
95. Molinero LL, Cubre A, Mora-Solano C, Wang Y, Alegre ML (2012) T cell receptor/CARMA1/NF-kappaB signaling controls T-helper (Th) 17 differentiation. Proc Natl Acad Sci U S A 109: 18529-18534.
96. Kuwabara T, Ishikawa F, Yasuda T, Aritomi K, Nakano H, et al. (2009) CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. J Immunol 183: 2513-2521.
97. Barbic J, Leef MF, Burns DL, Shahin RD (1997) Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect Immun 65: 4904-4908. (Pubitemid 27513528)
98. Khader SA, Gaffen SL, Kolls JK (2009) Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2: 403-411.
99. Fedele G, Bianco M, Debrie AS, Locht C, Ausiello CM (2011) Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol 186: 5388-5396.
100. Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt E, et al. (1995) Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur J Immunol 25: 823-829.
101. Mitsdoerffer M, Lee Y, Jager A, Kim HJ, Korn T, et al. (2010) Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 107: 14292-14297.
102. Norderhaug IN, Johansen FE, Schjerven H, Brandtzaeg P (1999) Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol 19: 481-508. (Pubitemid 30053175)
103. Kaetzel CS (2005) The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 206: 83-99.
104. Jaffar Z, Ferrini ME, Herritt LA, Roberts K (2009) Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J Immunol 182: 4507-4511.
105. van der Ark AA, Hozbor DF, Boog CJ, Metz B, van den Dobbelsteen GP, et al. (2012) Resurgence of pertussis calls for re-evaluation of pertussis animal models. Expert Rev Vaccines 11: 1121-1137.
106. Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, et al. (2006) Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2: e65.
107. Bart MJ, van Gent M, van der Heide HG, Boekhorst J, Hermans P, et al. (2010) Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics 11: 627.
108. Verwey WF, Thiele EH, et al. (1949) A simplified liquid culture medium for the growth of Hemophilus pertussis. J Bacteriol 58: 127-134.
109. Pennings JL, Rodenburg W, Imholz S, Koster MP, van Oostrom CT, et al. (2011) Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening. PLoS One 6: e18866.
110. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57: 289-300.
111. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
112. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
113. Lattin JE, Schroder K, Su AI, Walker JR, Zhang J, et al. (2008) Expression analysis of G Protein-Coupled Receptors in mouse macrophages. Immunome Res 4: 5.
114. Zollinger WD, Donets MA, Schmiel DH, Pinto VB, Labrie J, et al. (2010) Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine. Vaccine.
115. Stenger RM, Smits M, Kuipers B, Kessen SF, Boog CJ, et al. (2011) Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens. Clin Vaccine Immunol 18: 595-603.
116. Hijnen M, van Gageldonk PG, Berbers GA, van Woerkom T, Mooi FR (2005) The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli. Protein Expr Purif 41: 106-112. (Pubitemid 40406369)
117. Raychaudhuri S, Stuart JM, Altman RB (2000) Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput: 455-466.